Monoamine oxidase and mitochondrial respiration

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2310-2315

  Cohen, Gerald ^a   Kesler, Natasa ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

3 (4,5 Dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide (MTT); Dopamine; Glutathione; Mitochondria; Monoamine oxidase; Protein mixed disulfides; Respiration; Tyramine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ANIMALS; DISULFIDES; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; GLUTATHIONE; HYDROGEN PEROXIDE; MITOCHONDRIA; MONOAMINE OXIDASE; NADH, NADPH OXIDOREDUCTASES; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PYRUVIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS; TYRAMINE;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0032755436     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732310.x     Document Type: Article

References (45)

1. Akerboom T. P. M. and Sies H. (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 77, 373-382.
2. Ali M. S., Roche T. E., and Patel M. S. (1993) Identification of the essential cysteine residue in the active site of bovine pyruvate dehydrogenase. J. Biol. Chem. 268, 22353-22356.
3. Arenas J., Campos Y., Ribacoba R., Martin M. A., Rubio J. C., Ablanedo P., and Cabello A. (1998) Complex I defect in muscle from patients with Huntington's disease. Ann. Neurol. 43, 397-400.
4. Berridge M. V. and Tan A. S. (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303, 474-482.
5. Cassarino D. S. and Bennett J. P. Jr. (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Rev. 29, 1-25.
6. Chance B., Sies H., and Boveris A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605.
7. Clark J. B. and Nicklas W. J. (1970) The metabolism of rat brain mitochondria. Preparation and characterization. J. Biol. Chem. 245, 4724-4731.
8. Cohen G., Farooqui R., and Kesler N. (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 94, 4890-4894.
9. Cooper J. R., Bloom F. E., and Roth R. H. (1996) The Biochemical Basis of Neuropharmocology. Oxford University Press, New York.
10. Davey G. P., Peuchen S., and Clark J. B. (1998) Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J. Biol. Chem. 273, 12753-12757.
11. Flohe L. and Schlegel W. (1971) Glutathion-Peroxidase, IV. Intrazellulare Verteilung des Glutathion-Peroxidase-Systems in der Rattenleber. Hoppe Seylers Z. Physiol. Chem. 352, 1401-1410.
12. Forman H. J. and Boveris A. (1982) Superoxide radical and hydrogen peroxide in mitochondria, in Free Radicals in Biology, Vol. 5 (Pryor W. A., ed), pp. 65-87. Academic Press, New York.
13. Giulivi C. and Cadenas E. (1998) The role of mitochondrial glutathione in DNA base oxidation. Biochim. Biophys. Acta 1366, 265-274.
14. Gutman M., Mersmann H., Luthy J., and Singer P. (1970) Action of sulfhydryl inhibitors on different forms of the respiratory chain-linked reduced nicotinamide-adenine dinucleotide dehydrogenase. Biochemistry 9, 2678-2687.
15. Hauptmann N., Grimsby J., Shih J. C., and Cadenas E. (1996) The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch. Biochem. Biophys. 335, 295-304.
16. Holmgren A. (1985) Thioredoxin. Annu. Rev. Biochem. 54, 237-271.
17. Hornykiewicz O. and Kish S. J. (1986) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19-34.
18. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.
19. Ku H. H., Brunk U. T., and Sohal R. S. (1993) Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radic. Biol. Med. 15, 621-627.
20. Liu Y., Peterson D. A., Kimura H., and Schubert D. (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69, 581-593.
21. Lowry O., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
22. Maker H. S., Weiss C., Silides D. J., and Cohen G. (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione peroxidase via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36, 589-593.
23. Moreadith R. W. and Fiskum G. (1984) Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal. Biochem. 137, 360-367.
24. Olafsdottir K. and Reed D. J. (1988) Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. Biochim. Biophys. Acta 964, 377-382.
25. Panfili E., Sandri G., and Ernster L. (1991) Distribution of glutathione peroxidases and glutathione reduclase in rat brain mitochondria. FEBS Lett. 290, 35-37.
26. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., and Nussbaum R. L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
27. Przedborski S., Jackson-Lewis V., Muthane U., Jiang H., Ferreira M., Naini A. B., and Fahn S. (1993) Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann. Neurol. 34, 715-723.
28. Rabenstein D. L. and Millis K. K. (1995) Nuclear magnetic resonance study of the thioltransferase-catalyzed glutathione/glutathione disulfide interchange reaction. Biochim. Biophys. Acta 1249, 29-36.
29. Ragan C. I., Wilson M. T., Darley-Usmar V. M., and Lowe P. N. (1987) Sub-fractionation of mitochondria and isolation of the proteins of oxidative phosphorylation, in Mitochondria. A Practical Approach (Darley-Usmar V. M., Rickwood D., and Wilson M. T., eds), pp. 79-112. IRL Press, Oxford.
30. Reed D. J. (1990) Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30, 603-631.
31. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., Walter P., and Yaffee M. (1995) Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta 1271, 67-74.
32. 2+ efflux. Biochim. Biophys. Acta 1035, 300-305.
33. Schapira A. H. (1998) Mitochondrial dysfunction in neurodegenerative disorders. Biochim. Biophys. Acta 1366, 225-233.
34. Schapira A. H. (1999) Mitochondrial involvement in Parkinson's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta 1410, 159-170.
35. Schnaitman C., Erwin V. G., and Greenwalt J. W. (1967) The submitochondrial localization of monoamine oxidase. An enzymatic marker for the outer membrane of rat liver mitochondria. J. Cell Biol. 32, 719-735.
36. Schulz J. B., Matthews R. T., Klockgether T., Dichgans J., and Beal M. F. (1997) The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative disease. Mol. Cell. Biochem. 174, 193-197.
37. Sinet P. M., Heikkila R. E., and Cohen G. (1980) Hydrogen peroxide formation by rat brain in vivo. J. Neurochem. 34, 1421-1428.
38. Slater T. F., Sawyer B., and Strauli U. (1963) Studies on succinatetetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 77, 383-393.
39. Sohal R. S., Sohal B. H., and Orr W. C. (1995) Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. Free Rad. Biol. Med. 19, 499-504.
40. Swerdlow R. H., Parks J. K., Miller S. W., Tuttle J. B., Trimmer P. A., Sheehan J. P., Bennett J. P. Jr., Davis R. E., and Parker W. D. Jr. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663-671.
41. Tietze F. (1969) Enzymic method for the quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
42. Tipton K. F., Houslay M. D., and Mantle T. J. (1976) The nature and locations of the multiple forms of monoamine oxidase, in Monoamine Oxidase and Its Inhibitors, Ciba Foundation Symposium (Wolstenholme G. E. W. and Knight J., eds), pp. 5-33. Elsevier North-Holland, New York.
43. Werner P. and Cohen G. (1991) Intramitochondrial formation of oxidized glutathione during the oxidation of benzylamine by monoamine oxidase. FEBS Lett. 280, 44-46.
44. Werner P. and Cohen G. (1993) Glutathione disulfide (GSSG) as a marker of oxidative injury to brain mitochondria. Ann. NY Acad. Scid. 679, 364-369.
45. Zamzami N., Hirch T., Dallaporta B., Petit P. X., and Kroemer G. (1997) Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Biomembr. 29, 185-193.